These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


71 related items for PubMed ID: 1667944

  • 1. Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization.
    Waldo FB.
    J Clin Lab Immunol; 1991 Mar; 34(3):125-9. PubMed ID: 1667944
    [Abstract] [Full Text] [Related]

  • 2. Response to mucosal antigen challenge in IgA nephropathy.
    Layward L, Allen AC, Hattersley JM, Harper SJ, Feehally J.
    Exp Nephrol; 1995 Mar; 3(5):300-7. PubMed ID: 7583052
    [Abstract] [Full Text] [Related]

  • 3. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M, Sajadi Tabassi SA, Jaafari MR.
    Int J Pharm; 2006 Aug 17; 319(1-2):37-43. PubMed ID: 16701972
    [Abstract] [Full Text] [Related]

  • 4. IL-12 is an effective adjuvant for induction of mucosal immunity.
    Boyaka PN, Marinaro M, Jackson RJ, Menon S, Kiyono H, Jirillo E, McGhee JR.
    J Immunol; 1999 Jan 01; 162(1):122-8. PubMed ID: 9886377
    [Abstract] [Full Text] [Related]

  • 5. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec 01; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 6. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS.
    J Immunol; 1982 Jul 01; 129(1):139-44. PubMed ID: 7086128
    [Abstract] [Full Text] [Related]

  • 7. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
    Tafaghodi M, Jaafari MR, Sajadi Tabassi SA.
    Eur J Pharm Biopharm; 2006 Oct 01; 64(2):138-45. PubMed ID: 16797952
    [Abstract] [Full Text] [Related]

  • 8. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS.
    J Immunol; 1983 Apr 01; 130(4):1634-9. PubMed ID: 6601133
    [Abstract] [Full Text] [Related]

  • 9. Systemic immune response after mucosal immunization in patients with IgA nephropathy.
    Waldo FB.
    J Clin Immunol; 1992 Jan 01; 12(1):21-6. PubMed ID: 1551939
    [Abstract] [Full Text] [Related]

  • 10. A polymeric IgA response in serum can be produced by parenteral immunization.
    Mascart-Lemone F, Duchateau J, Conley ME, Delacroix DL.
    Immunology; 1987 Aug 01; 61(4):409-13. PubMed ID: 3443449
    [Abstract] [Full Text] [Related]

  • 11. Controlled field trials with oral and nasal immunization against tetanus in humans.
    Mayr A, Baljer G, Baljer E, Sailer J.
    Dev Biol Stand; 1978 Aug 01; 41():31-8. PubMed ID: 753660
    [Abstract] [Full Text] [Related]

  • 12. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M, Yasuda Y, Kozuka S, Miura Y, Taniguchi T, Matano K, Goto N, Tochikubo K.
    Vaccine; 1998 Oct 01; 16(17):1620-6. PubMed ID: 9713937
    [Abstract] [Full Text] [Related]

  • 13. Tetanus toxoid immunization coverage among women in zone 3 of Dhaka city: the challenge of reaching all women of reproductive age in urban Bangladesh.
    Perry H, Weierbach R, Hossain I, Islam R.
    Bull World Health Organ; 1998 Oct 01; 76(5):449-57. PubMed ID: 9868835
    [Abstract] [Full Text] [Related]

  • 14. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
    Bakke H, Samdal HH, Holst J, Oftung F, Haugen IL, Kristoffersen AC, Haugan A, Janakova L, Korsvold GE, Krogh G, Andersen EA, Djupesland P, Holand T, Rappuoli R, Haneberg B.
    Scand J Immunol; 2006 Mar 01; 63(3):223-31. PubMed ID: 16499576
    [Abstract] [Full Text] [Related]

  • 15. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG, Culbertson NJ.
    J Immunol; 1985 Jul 01; 135(1):185-91. PubMed ID: 2582031
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.